" class="no-js "lang="en-US"> Therapeutic Solutions International - Medtech Alert
Sunday, October 19, 2025
Therapeutic Solutions International | Pharmtech Focus

Therapeutic Solutions International

About Therapeutic Solutions International

Therapeutic Solutions International

Currently the Company is focused on immune modulation for the treatment of several specific diseases. Immune modulation refers to the ability to upregulate (make more active) or downregulate (make less active) one’s immune system.

Activating one’s immune system is now an accepted method to treat certain cancers, reduce recovery time from viral or bacterial infections and to prevent illness. Additionally, inhibiting one’s immune system is vital for reducing inflammation, autoimmune disorders and allergic reactions.

TSOI is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, traumatic brain injury, and for daily health.

Related Story

Therapeutic Solutions International Identifies and Files Patent on Novel Mechanism of Action of Its FDA Phase III Cleared JadiCell™ Treatment of COVID-19 and Delta Variant

August 18 2021

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today novel data and filing of a […]